218 related articles for article (PubMed ID: 30262865)
1. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
[TBL] [Abstract][Full Text] [Related]
2. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
[TBL] [Abstract][Full Text] [Related]
3. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
7. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
8. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.
Balamurugan K; Sharan S; Klarmann KD; Zhang Y; Coppola V; Summers GH; Roger T; Morrison DK; Keller JR; Sterneck E
Nat Commun; 2013; 4():1662. PubMed ID: 23575666
[TBL] [Abstract][Full Text] [Related]
9. PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.
Sheshadri N; Poria DK; Sharan S; Hu Y; Yan C; Koparde VN; Balamurugan K; Sterneck E
Cell Death Dis; 2021 Nov; 12(11):1038. PubMed ID: 34725321
[TBL] [Abstract][Full Text] [Related]
10. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
[TBL] [Abstract][Full Text] [Related]
12. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
[TBL] [Abstract][Full Text] [Related]
13. C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.
Pawar SA; Sarkar TR; Balamurugan K; Sharan S; Wang J; Zhang Y; Dowdy SF; Huang AM; Sterneck E
Proc Natl Acad Sci U S A; 2010 May; 107(20):9210-5. PubMed ID: 20439707
[TBL] [Abstract][Full Text] [Related]
14. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.
Min Y; Ghose S; Boelte K; Li J; Yang L; Lin PC
Oncogene; 2011 Dec; 30(49):4901-9. PubMed ID: 21666710
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
16. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
[TBL] [Abstract][Full Text] [Related]
17. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
18. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
19. C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.
Wang D; Cheng X; Li Y; Guo M; Zhao W; Qiu J; Zheng Y; Meng M; Ping X; Chen X; Wang S; Luo J; Luo Q; Ma X; Xu L
Oncogene; 2020 Jan; 39(4):833-848. PubMed ID: 31562393
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
